ACUTAAS
Acutaas Chemicals
Each stock's 10,000-path forecast, rendered as light.
Acutaas Chemicals (ACUTAAS) Stock Analysis & Case Study
Is ACUTAAS a good buy? The data-driven verdict.
Acutaas Chemicals (ACUTAAS) trades at ₹3,250,on the numbers it worth a closer look, a Downstox Snapshot Score of 55/100.
On the numbers, Acutaas Chemicals (ACUTAAS) worth a closer look, a Downstox Snapshot Score of 55/100, weighing expensive at 74.7× earnings, ROE of 24.0%, a 93% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
ACUTAAS fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is ACUTAAS overvalued? ACUTAAS P/E vs its sector
ACUTAAS's P/E of 74.7× sits above the sector peer median of 15.9×, so on earnings it screens richer than peers, while its 0.05% dividend yield is below the peer median of 1.65%.
ACUTAAS share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of ACUTAAS history (81%/yr drift, 46%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| ACUTAAS 2027 | ₹3,591 | ₹6,536 | ₹11,879 | +101% |
| ACUTAAS 2028 | ₹5,750 | ₹13,167 | ₹30,059 | +306% |
| ACUTAAS 2029 | ₹9,627 | ₹26,518 | ₹72,625 | +717% |
| ACUTAAS 2030 | ₹16,493 | ₹53,735 | ₹1,75,518 | +1555% |
| ACUTAAS 2031 | ₹28,532 | ₹1,07,711 | ₹4,06,902 | +3218% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability ACUTAAS goes up, or doubles?
The bull case for ACUTAAS
- High return on equity (24.0%), the business compounds shareholder capital efficiently, the hallmark of a quality franchise.
- Strong ROCE (31.6%) shows the core business earns well above its cost of capital.
- A 10,000-path probability model puts a 93% chance the price is higher in a year, with a median target of ₹6,536 (+101%).
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹72,625.
The bear case & risks
- A rich 74.7× P/E leaves a thin margin of safety if growth slows.
- A steep 16.1× price-to-book means most of the value is intangible/expectations, not assets on the books.
- High historical volatility (46%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹9,627.
ACUTAAS volatility & expected range, how bumpy is the ride?
Over the last 2.0 years ACUTAAS compounded at 81%/year with annualized volatility of 46%. That volatility implies a 1-year 80% range of ₹3,591–₹11,879, the honest backbone behind any single price target.
ACUTAAS price forecast, the full 60-month probability fan
ACUTAAS price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds ACUTAAS hits common targets within the simulated horizon?
Full multi-horizon detail on the ACUTAAS price target & forecast page.
ACUTAAS Piotroski F-Score: 4/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. ACUTAAS scores 4/9,mixed financial health.
ACUTAAS MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy ACUTAAS with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| ZerodhaCHEAPEST | 36.4% | 2.7× |
| Groww | 36.5% | 2.7× |
Compare every broker on the ACUTAAS MTF page.
ACUTAAS vs peers,sector comparison
About Acutaas Chemicals: sector, index & market-cap context
Acutaas Chemicals (ACUTAAS) is a mid-cap NSE-listed company, and a constituent of the Nifty 200 index group, with a market capitalisation of ₹26,623 Cr. See more Nifty 200 stocks.
How the ACUTAAS Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Acutaas Chemicals's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
ACUTAAS analysis, FAQs
Is Acutaas Chemicals (ACUTAAS) a good buy?
On the numbers, Acutaas Chemicals (ACUTAAS) worth a closer look, a Downstox Snapshot Score of 55/100, weighing expensive at 74.7× earnings, ROE of 24.0%, a 93% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is ACUTAAS overvalued or undervalued?
ACUTAAS trades at 74.7× earnings versus a peer median of 15.9×, so it screens richer than its sector peers.
What is the ACUTAAS share price target for 2031?
ACUTAAS's probability-weighted 2031 median target is ₹1,07,711, with an 80% range of ₹28,532–₹4,06,902 (10,000-path Monte-Carlo).
What is the probability ACUTAAS doubles in 5 years?
The modelled probability of ACUTAAS reaching ₹6,492 (2×) within 5 years is 100%.
What is the bull case for ACUTAAS?
High return on equity (24.0%), the business compounds shareholder capital efficiently, the hallmark of a quality franchise. Strong ROCE (31.6%) shows the core business earns well above its cost of capital. A 10,000-path probability model puts a 93% chance the price is higher in a year, with a median target of ₹6,536 (+101%).
What are the risks in ACUTAAS?
A rich 74.7× P/E leaves a thin margin of safety if growth slows. A steep 16.1× price-to-book means most of the value is intangible/expectations, not assets on the books. High historical volatility (46%/yr) means a wide, bumpy range of outcomes, size positions accordingly.